Current screening, design, and delivery approaches to address low permeability of chemically synthesized modalities in drug discovery and early clinical development
Authors:
- 24 June 2023
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 28 (9) , 103685
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation DevelopmentJournal of Pharmaceutical Sciences, 2010
- Differences in the expression of endogenous efflux transporters inMDR1‐transfected versus wildtype cell lines affect P‐glycoprotein mediated drug transportBritish Journal of Pharmacology, 2010
- Segmental Dependent Transport of Low Permeability Compounds along the Small Intestine Due to P-Glycoprotein: The Role of Efflux Transport in the Oral Absorption of BCS Class III DrugsMolecular Pharmaceutics, 2008
- Development and Application of Physiologically Based Pharmacokinetic-Modeling Tools to Support Drug DiscoveryChemistry & Biodiversity, 2005
- Permeability Dominates in Vivo Intestinal Absorption of P-gp Substrate with High Solubility and High PermeabilityMolecular Pharmaceutics, 2005
- The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailabilityJournal of Controlled Release, 2004
- Current prodrug strategies via membrane transporters/receptorsExpert Opinion on Biological Therapy, 2002
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002
- Membrane Transport of Drugs in Different Regions of the Intestinal Tract of the RatJournal of Pharmaceutical Sciences, 1998
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997